Web Desc
Advancing Vaccines in the Genomics Era
Organizer(s): Bali Pulendran, Chris Wilson and Rino Rappuoli
Date: October 31 - November 04, 2013
Location: Windsor Barra Hotel, Rio de Janeiro, Barra da Tijuca, Brazil
Sponsored by FAPERJ – Rio de Janeiro State Agency for Research Development. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
For important information on the coronavirus, please click here
Summary of Meeting:
A direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring.
Global Health Travel Award Deadline: June 4 2013
Scholarship Deadline: June 27 2013
Discounted Abstract Deadline: June 27 2013
Abstract Deadline: July 30 2013
Discounted Registration Deadline: August 29 2013
Abstacts when book is in proofing process


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates FoundationFAPERJ – Rio de Janeiro State Agency for Research Development
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Dynavax Technologies Corporation

Novartis Vaccines and Diagnostics
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI108157-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Thursday, October 31 | 4:00PM - 8:00PM
Arrival and Registration
Room: Foyer


Friday, November 01 | 7:30AM - 8:30AM
Breakfast
Room: Individual Hotel


Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 1 of 7
* Rafick Sekaly, Case Western Reserve University, USA

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 2 of 7
* J. Christopher Love, Massachusetts Institute of Technology, USA

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 3 of 7
Daniel Kastner, National Institutes of Health, USA
Understanding Human Immunity from Experiments of Nature

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 4 of 7
Thomas R. Hawn, University of Washington, USA
Genetic Dissection of Innate Immunity during BCG Vaccination

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 5 of 7
Mary Carrington, NCI, National Institutes of Health, USA
Immunogenetics of Spontaneous Control of HIV

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 6 of 7
Petter Brodin, Karolinska Institutet, Sweden
Short Talk: Separating Genetic and Environmental Influences in the Human Immune System

Friday, November 01 | 8:30AM - 11:15AM
Genetic Dissection of Immunity
Room: Louvre I + II

Speaker 7 of 7
Tomer Hertz, Ben-Gurion University of the Negev, Israel
Short Talk: HLA A*02 Modifies Vaccine Efficacy in the RV144 Thai Trial

Friday, November 01 | 9:20AM - 9:40AM
Coffee Break
Room: Foyer


Friday, November 01 | 10:00AM - 10:00AM
On Own for Lunch and Recreation


Friday, November 01 | 11:15AM - 12:15PM
Keynote Address
Room: Louvre I + II

Speaker 1 of 2
* Chris Wilson, Bill & Melinda Gates Foundation, USA

Friday, November 01 | 11:15AM - 12:15PM
Keynote Address
Room: Louvre I + II

Speaker 2 of 2
Rino Rappuoli, GlaxoSmithKline Vaccines, Italy
Designing Vaccines for the 21st Century Society

Friday, November 01 | 12:15PM - 1:00PM
Poster Setup
Room: Louvre III + IV


Friday, November 01 | 1:00PM - 10:00PM
Poster Viewing
Room: Louvre III + IV


Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 1 of 7
* Andrew B. Ward, The Scripps Research Institute, USA

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 2 of 7
* Tomer Hertz, Ben-Gurion University of the Negev, Israel

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 3 of 7
Elizabeth Ernestina Godoy-Lozano, Instituto Nacional de Salud Pública, Mexico
B Cells Repertoire Analysis in Patients with Dengue Fever and Dengue Hemorrhagic Fever

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 4 of 7
Duane R. Wesemann, Harvard Medical School, USA
Microbial Colonization Influences Primary Immunoglobulin Diversification in the Gut Lamina Propria

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 5 of 7
Shaikh Meshbahuddin Ahmad, International Centre for Diarrhoeal Disease Research (icddr,b), Bangladesh
Vitamin A Supplementation during Pregnancy Interfere Passive Influenza Antibody Transfer to Infants

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 6 of 7
Juan C. Alvarez, Universidad de Antioquia, Colombia
Using Reverse Vaccinology to Identify Antigen Candidates for a Molecularly-Defined Vaccine Against Leishmania (Viannia) panamensis

Friday, November 01 | 2:30PM - 4:00PM
Workshop 1: Immunity to Infections
Room: Louvre I + II

Speaker 7 of 7
Arman Bashirova, SAIC-Frederick, USA
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection

Friday, November 01 | 4:00PM - 4:30PM
Coffee Available
Room: Foyer


Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 1 of 6
* Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland

Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 2 of 6
* Scott D. Boyd, Stanford University, USA

Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 3 of 6
Rafi Ahmed, Emory University School of Medicine, USA
Vaccination and Immune Memory

Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 4 of 6
Rafick Sekaly, Case Western Reserve University, USA
Inflammation, a Driver of the Immune Response to Vaccines

Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 5 of 6
J. Christopher Love, Massachusetts Institute of Technology, USA
Microtools for Probing T Cell Responses

Friday, November 01 | 5:30PM - 7:30PM
Genomics of T Cell Responses to Vaccination
Room: Louvre I + II

Speaker 6 of 6
Arno C. Andeweg, Erasmus MC, Netherlands
Short Talk: Dendritic Cell Vaccination of HIV-Infected Individuals Results in a Major and Sustained Shift of the Blood Transcriptome

Friday, November 01 | 7:30PM - 8:30PM
Social Hour with Lite Bites
Room: Louvre III + IV


Friday, November 01 | 7:30PM - 10:00PM
Poster Session 1
Room: Louvre III + IV


Saturday, November 02 | 7:30AM - 8:30AM
Breakfast
Room: Individual Hotel


Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 1 of 7
* Ofer Levy, Boston Children's Hospital, USA

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 2 of 7
* Jorg J. Goronzy, Stanford University School of Medicine, USA

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 3 of 7
Bali Pulendran, Stanford University School of Medicine, USA
Systems Vaccinology

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 4 of 7
Alan Aderem, Center for Infectious Disease Research, USA
Systems Vaccinology: Using the Tools of Systems Biology to Enable Rational Vaccine Design

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 5 of 7
Mark M. Davis, Stanford University School of Medicine, USA
New Approaches and Analyses of Influenza Vaccination

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 6 of 7
Danilo R. Casimiro, Aeras, USA
Genome-Wide Transcriptional Analyses for Biomarker Discovery in Vaccine R&D

Saturday, November 02 | 8:30AM - 11:30AM
Systems Biological Approaches to Vaccination
Room: Louvre I + II

Speaker 7 of 7
Junichi Ito, National Institute of Biomedical Innovation (NIBIO), Japan
Short Talk: A Comprehensive Analysis of miRNA Expression Profile in Human Serum Collected from Type-A Influenza Vaccine Clinical Trial

Saturday, November 02 | 9:40AM - 10:00AM
Coffee Break
Room: Foyer


Saturday, November 02 | 10:00AM - 10:00AM
On Own for Lunch and Recreation


Saturday, November 02 | 11:30AM - 1:00PM
Poster Setup
Room: Louvre III + IV


Saturday, November 02 | 1:00PM - 10:00PM
Poster Viewing
Room: Louvre III + IV


Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 1 of 9
* Petter Brodin, Karolinska Institutet, Sweden

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 2 of 9
* Hana Golding, US Food and Drug Administration, USA

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 3 of 9
Helder I. Nakaya, Emory University, USA
Large Scale Network Modeling Reveals Distinctive Transcriptomic Programs in Vaccine Antibody Response

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 4 of 9
Luis Miguel Franco, National Institutes of Health, USA
Integrative Genomic Analysis of the Human Immune Response to Influenza Vaccination

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 5 of 9
Katie L. Flanagan, Monash University, Australia
Temporal Heterogeneity in the Systemic Immune Pathway Response to Measles Vaccination

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 6 of 9
Magali Matsumiya, University of Oxford, UK
The Immune Response to MVA85A in Infants

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 7 of 9
Gabriel C. Wu, University of Texas, Austin, USA
A Proteomic Analysis of the Human Antibody Response to the Seasonal Trivalent Influenza Vaccine

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 8 of 9
Anwar Hashem, King Abdulaziz University, Saudi Arabia
A Universal Influenza Vaccine Based on the HA2 Subunit of the Viral Hemaggultinin

Saturday, November 02 | 2:30PM - 4:30PM
Workshop 2: Immunity to Vaccines
Room: Louvre I + II

Speaker 9 of 9
Sylvie Bertholet, GlaxoSmithKline Vaccines, USA
Reinventing the Gene Vaccine: SAM® Vaccine Against Influenza

Saturday, November 02 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 1 of 7
* Mark M. Davis, Stanford University School of Medicine, USA

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 2 of 7
* Scott Presnell, Benaroya Research Institute, USA

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 3 of 7
Scott D. Boyd, Stanford University, USA
Deep Sequencing of Human Antibody Repertoires during Influenza Vaccination Shows Convergent Antibody Rearrangements and Seroconversion Signatures

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 4 of 7
Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Dissecting the Antibody Response to Pathogens and Self Antigens

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 5 of 7
Hana Golding, US Food and Drug Administration, USA
Expanding the Antibody Repertoire and Avidity with Adjuvants

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 6 of 7
Brandon DeKosky, University of Kansas, USA
Short Talk: Vaccine Response Analysis by High-Throughput Sequencing of the Paired Human Immunoglobulin Heavy and Light Chain Repertoire

Saturday, November 02 | 5:00PM - 7:15PM
Genomics of Antibody Responses to Vaccination
Room: Louvre I + II

Speaker 7 of 7
Frances Eun-Hyung Lee, Emory University, USA
Short Talk: Heterogeneity of Antibody Secreting Cell Subsets in Blood after Vaccination and Bone Marrow in Healthy Adults: Identification of Human Long-Lived Plasma Cells

Saturday, November 02 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Louvre III + IV


Saturday, November 02 | 7:30PM - 10:00PM
Poster Session 2
Room: Louvre III + IV


Sunday, November 03 | 7:30AM - 8:30AM
Breakfast
Room: Individual Hotel


Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 1 of 7
* Bonnie B. Blomberg, University of Miami School of Medicine, USA

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 2 of 7
* Danilo R. Casimiro, Aeras, USA

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 3 of 7
Peter D. Kwong, NIAID, National Institutes of Health, USA
Structural Vaccinology

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 4 of 7
Ian A. Wilson, The Scripps Research Institute, USA
Structural Insights into HIV and Influenza Antigen Design

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 5 of 7
Rhea N. Coler, Infectious Disease Research Institute, USA
Reverse Vaccinology for TB Antigen Discovery

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 6 of 7
Scott Presnell, Benaroya Research Institute, USA
Module Repertoire Analysis Applied to Vaccine Response Studies

Sunday, November 03 | 8:30AM - 11:30AM
Genomic and Structural Approaches to Antigen and Adjuvant Di
scovery, Design and Validation

Room: Louvre I + II

Speaker 7 of 7
Charalambos (Harry) D. Partidos, Takeda Vaccines, Inc., USA
Short Talk: Dissecting the Immune Responses to DENVax, a Novel Tetravalent Dengue Vaccine

Sunday, November 03 | 9:40AM - 10:00AM
Coffee Break
Room: Foyer


Sunday, November 03 | 10:00AM - 10:00AM
On Own for Lunch and Recreation


Sunday, November 03 | 11:30AM - 1:00PM
Poster Setup
Room: Louvre III + IV


Sunday, November 03 | 1:00PM - 10:00PM
Poster Viewing
Room: Louvre III + IV


Sunday, November 03 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 1 of 6
* Chris Wilson, Bill & Melinda Gates Foundation, USA

Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 2 of 6
* Rhea N. Coler, Infectious Disease Research Institute, USA

Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 3 of 6
Mauro Martins Teixeira, Universidade Federal de Minas Gerais, Brazil
Mechanisms of Resistance and Disease in Dengue Infection

Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 4 of 6
Ricardo T. Gazzinelli, Fundação Oswaldo Cruz-CPqRR, Brazil
Exploring Multi-Copy Gene Families in the Development of Trypanosoma cruzi as a Live Attenuated Vaccine Vector

Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 5 of 6
Adrian V. S. Hill, Jenner Institute, University of Oxford, UK
Can Genes Help Design New Vaccines?

Sunday, November 03 | 5:00PM - 7:00PM
Lessons to Be Learned from Other Fields
Room: Louvre I + II

Speaker 6 of 6
Andrew B. Ward, The Scripps Research Institute, USA
Short Talk: Cryo-EM Studies of HIV-1 Env

Sunday, November 03 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Louvre III + IV


Sunday, November 03 | 7:30PM - 10:00PM
Poster Session 3
Room: Louvre III + IV


Monday, November 04 | 7:30AM - 8:30AM
Breakfast
Room: Individual Hotel


Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 1 of 7
* Rino Rappuoli, GlaxoSmithKline Vaccines, Italy

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 2 of 7
* Robert L. Coffman, Dynavax Technologies, USA

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 3 of 7
Jorg J. Goronzy, Stanford University School of Medicine, USA
Dissecting the T Cell Response in the Elderly

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 4 of 7
Bonnie B. Blomberg, University of Miami School of Medicine, USA
Biomarkers of Vaccine Efficacy in the Elderly

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 5 of 7
Ofer Levy, Boston Children's Hospital, USA
Microphysiologic Modeling of Immune Responses to Inform Age-Specific Vaccine Development

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 6 of 7
Andrew J. Pollard, University of Oxford, UK
Transcriptional Signatures of Adjuvanted Influenza Vaccines in Children

Monday, November 04 | 8:30AM - 11:30AM
Immunology of Vaccination in the Young and Elderly
Room: Alhambra I + II

Speaker 7 of 7
Thomas J. Scriba, University of Cape Town, South Africa
Short Talk: Correlates of Progression from Mycobacterium tuberculosis Infection to Tuberculosis Disease in Adolescents

Monday, November 04 | 9:40AM - 10:00AM
Coffee Break
Room: Foyer


Monday, November 04 | 10:23AM - 10:23AM
Departure


*Session Chair
†Invited, not yet responded.

Monday, November 04 | 11:30AM - 12:30PM
Lunch
Room: El Pardo


Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 1 of 6
* Ian A. Wilson, The Scripps Research Institute, USA

Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 2 of 6
* Andrew J. Pollard, University of Oxford, UK

Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 3 of 6
Lynda G. Tussey, VaxInnate Corporation, USA
Modifying the Agonist Properties of Flagellin to Improve Vaccine Performance

Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 4 of 6
Ennio De Gregorio, GlaxoSmithKline Vaccines, Italy
Vaccine Adjuvants: From Empiricism to Rational Design

Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 5 of 6
Robert L. Coffman, Dynavax Technologies, USA
Advancing TLR9 Ligands as Vaccine Adjuvants in Humans

Monday, November 04 | 12:30PM - 2:30PM
Translation of Immunological Concepts to the Clinic
Room: Alhambra I + II

Speaker 6 of 6
Wayne C. Koff, Human Vaccines Project, USA
Short Talk: The Case for a Human Vaccines Project to Accelerate Global Disease Prevention